Therapeutic metastatic prostate cancer vaccines: lessons learnt from urologic oncology

INTRODUCTION: Therapeutic cancer vaccines have been recognized as a promising treatment option in clinical oncology for nearly three decades. However, despite many efforts, only one cancer vaccine – sipuleucel-T, activating the anti-PAP (prostatic acid phosphatase) immune response, has obtained Food...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasek, Witold, Zapała, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2021
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552937/
https://www.ncbi.nlm.nih.gov/pubmed/34729217
http://dx.doi.org/10.5173/ceju.2021.0094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552937/
https://www.ncbi.nlm.nih.gov/pubmed/34729217
http://dx.doi.org/10.5173/ceju.2021.0094

Ejemplares similares